Last reviewed · How we verify

NCT06280599

Transitional Care Model for Patients With Stroke

Recruiting now NA Last updated 3 April 2024
What this trial tests

NA trial testing Transitional care model in Stroke in 80 participants. Currently enrolling.

Timeline
1 September 2023
Primary endpoint
1 April 2024
29 April 2024

Quick facts

Lead sponsorKaohsiung Medical University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment80
Start date1 September 2023
Primary completion1 April 2024
Estimated completion29 April 2024
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Kaohsiung Medical University

Who can join

Adults 18 to 90, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with stroke benefitted from superior improvements in physical function, particularly when performing activities of daily living, fewer visits to the emergency room, less depression symptoms, and improved health-related quality of life thanks to transitional model care. Despite widespread implementation of transitional care for stroke patients, intervention effectiveness remains inconclusive, and another concern with transitional care for patients is the scarcity of effects on specific findings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transitional care model

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Kaohsiung Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06280599.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing